Prostatic Neoplasms Recruiting Phase 3 Trials for Bicalutamide (DB01128)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02531516An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASTreatment